prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |review
* Lifestyle modification should be adjunctive therapy for all patients recommended for pharmacologic therapy.

† For patients with multiple risk factors, clinicians should consider drugs as initial therapy plus lifestyle modifications.

‡ For those with heart failure, renal insufficiency, or diabetes.

TOD/CCD = target organ disease/clinical cardiovascular disease.